Metis Global Partners LLC reduced its stake in shares of Xylem Inc. (NYSE:XYL – Free Report) by 7.7% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 52,161 shares of the industrial products company’s stock after selling 4,321 shares during the quarter. Metis Global Partners LLC’s holdings in Xylem were worth $6,748,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. AFG Fiduciary Services Limited Partnership purchased a new stake in Xylem during the 2nd quarter worth approximately $275,000. IFM Investors Pty Ltd lifted its position in Xylem by 11.6% during the 2nd quarter. IFM Investors Pty Ltd now owns 54,073 shares of the industrial products company’s stock worth $6,995,000 after acquiring an additional 5,617 shares during the period. BROOKFIELD Corp ON grew its stake in Xylem by 26.5% during the 1st quarter. BROOKFIELD Corp ON now owns 16,375 shares of the industrial products company’s stock valued at $1,956,000 after purchasing an additional 3,430 shares during the last quarter. Nordea Investment Management AB raised its stake in shares of Xylem by 10.9% in the second quarter. Nordea Investment Management AB now owns 29,826 shares of the industrial products company’s stock worth $3,830,000 after purchasing an additional 2,926 shares during the last quarter. Finally, Boston Family Office LLC boosted its position in Xylem by 10.6% in the first quarter. Boston Family Office LLC now owns 86,887 shares of the industrial products company’s stock valued at $10,380,000 after buying an additional 8,308 shares during the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.
Xylem Stock Up 0.6%
Shares of XYL opened at $151.27 on Friday. The stock has a 50 day moving average price of $145.43 and a 200 day moving average price of $135.62. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.43 and a current ratio of 1.96. The stock has a market capitalization of $36.83 billion, a price-to-earnings ratio of 38.89, a PEG ratio of 2.50 and a beta of 1.15. Xylem Inc. has a one year low of $100.47 and a one year high of $154.27.
Xylem Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Thursday, August 28th were paid a $0.40 dividend. The ex-dividend date of this dividend was Thursday, August 28th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.1%. Xylem’s dividend payout ratio (DPR) is 41.13%.
Insider Activity
In other news, Director Victoria D. Harker sold 1,700 shares of the stock in a transaction on Tuesday, November 4th. The stock was sold at an average price of $148.14, for a total transaction of $251,838.00. Following the completion of the transaction, the director directly owned 16,875 shares in the company, valued at approximately $2,499,862.50. This represents a 9.15% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CAO Geri-Michelle Mcshane sold 1,000 shares of the business’s stock in a transaction dated Friday, September 5th. The shares were sold at an average price of $139.96, for a total transaction of $139,960.00. Following the completion of the sale, the chief accounting officer owned 2,957 shares in the company, valued at approximately $413,861.72. This trade represents a 25.27% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 13,121 shares of company stock valued at $1,982,459. 0.27% of the stock is currently owned by insiders.
Wall Street Analyst Weigh In
Several brokerages recently issued reports on XYL. Robert W. Baird set a $178.00 target price on shares of Xylem in a report on Wednesday, October 29th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Xylem in a report on Wednesday, October 8th. Zacks Research raised Xylem from a “hold” rating to a “strong-buy” rating in a report on Monday, September 22nd. Argus set a $170.00 price objective on shares of Xylem in a report on Wednesday, October 29th. Finally, Citigroup raised their target price on Xylem from $173.00 to $182.00 and gave the company a “buy” rating in a research report on Wednesday, October 29th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and five have issued a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $166.90.
Read Our Latest Analysis on XYL
Xylem Profile
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Recommended Stories
- Five stocks we like better than Xylem
- Using the MarketBeat Dividend Tax Calculator
- MarketBeat Week in Review – 11/03 – 11/07
- Roth IRA Calculator: Calculate Your Potential Returns
- OpenAI’s Restructuring Sets up What Could Be the Biggest IPO Ever
- Insider Trading – What You Need to Know
- 2 Rare Earth Stocks the U.S. Government Doesn’t Want to Fail
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
